Clinical Trials: SEARCH[Study] TILT[Study:StudyFirstPostDate] AREA[ConditionSearch] Disease
First Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 … 4715 4716 4717 4718 4719 4720 4721 4722 4723 4724 4725 4726 4727 4728 4729 4730 4731 4732 4733 4734 4735 4736 4737 4738 4739 4740 4741 4742 4743 4744 4745 4746 4747 4748 4749 4750 4751 4752 4753 4754 4755 4756 4757 4758 4759 Next Last
#
NCTID/Status
Study
Last Changed
236701
NCT00362310
Completed
Completed
Treatment of Classical Non-HIV-Related Kaposi's Sarcoma With the Antiviral Drug Indinavir
Conditions: Classical Kaposi's Sarcoma
Intervention: Indinavir
Conditions: Classical Kaposi's Sarcoma
Intervention: Indinavir
April 11, 2008
236702
NCT00397982
Completed
Completed
Temsirolimus and Bevacizumab in Treating Patients With Stage III or Stage IV Malignant Melanoma
Conditions: Recurrent Melanoma; Stage IIIB Skin Melanoma; Stage IIIC Skin Melanoma; Stage IV Skin Melanoma
Intervention: Bevacizumab, Laboratory Biomarker Analysis, Temsirolimus, Therapeutic Conventional Surgery
Conditions: Recurrent Melanoma; Stage IIIB Skin Melanoma; Stage IIIC Skin Melanoma; Stage IV Skin Melanoma
Intervention: Bevacizumab, Laboratory Biomarker Analysis, Temsirolimus, Therapeutic Conventional Surgery
May 5, 2017
236703
NCT00391300
Unknown status
Unknown status
Bioelectric Field Imaging in Diagnosing Melanoma and Other Skin Cancers in Patients With Skin Lesions
Conditions: Melanoma (Skin); Non-melanomatous Skin Cancer
Intervention: Bioelectric Field Imaging, Biopsy, Histopathologic Examination
Conditions: Melanoma (Skin); Non-melanomatous Skin Cancer
Intervention: Bioelectric Field Imaging, Biopsy, Histopathologic Examination
December 17, 2013
236704
NCT00387751
Completed
Completed
Bevacizumab and Sorafenib in Treating Patients With Unresectable Stage III or Stage IV Malignant Melanoma
Conditions: Recurrent Melanoma; Stage III Skin Melanoma; Stage IV Skin Melanoma
Intervention: Bevacizumab, Laboratory Biomarker Analysis, Pharmacological Study, Sorafenib Tosylate
Conditions: Recurrent Melanoma; Stage III Skin Melanoma; Stage IV Skin Melanoma
Intervention: Bevacizumab, Laboratory Biomarker Analysis, Pharmacological Study, Sorafenib Tosylate
October 19, 2017
236705
NCT00339937
Completed
Completed
Studies of Human Herpesvirus 8 and Kaposi's Sarcoma in Sicily
Conditions: Kaposi s Sarcoma (KS)
Conditions: Kaposi s Sarcoma (KS)
October 18, 2019
236706
NCT00339326
Completed
Completed
Risk Factors for Non-HIV-Related Kaposi s Sarcoma
Conditions: Kaposi's Sarcoma
Conditions: Kaposi's Sarcoma
September 7, 2019
236707
NCT01025089
Active, not recruiting
Active, not recruiting
Chemotherapy Plus Cetuximab Followed by Surgical Resection in Patients With Locally Advanced or Recurrent Thymoma or Thymic Carcinoma
Conditions: Thymoma; Thymic Carcinoma; Clinical Masaoka Stage II to IVA
Intervention: Cetuximab, Cisplatin, Doxorubicin & Cyclophosphamide
Conditions: Thymoma; Thymic Carcinoma; Clinical Masaoka Stage II to IVA
Intervention: Cetuximab, Cisplatin, Doxorubicin & Cyclophosphamide
April 5, 2019
236708
NCT00316706
Completed
Completed
Human Papilloma Virus (HPV) Vaccine Trial in Young Adolescent Women With GlaxoSmithKline Biologicals' (GSK Bio) HPV-16/18 Vaccine
Conditions: Cervical Intraepithelial Neoplasia; Papillomavirus Infection
Intervention: GSK Biologicals' HPV-16/18 Vaccine (Cervarix™), Havrix™
Conditions: Cervical Intraepithelial Neoplasia; Papillomavirus Infection
Intervention: GSK Biologicals' HPV-16/18 Vaccine (Cervarix™), Havrix™
September 13, 2012
236709
NCT01011439
Terminated
Terminated
Phase II Study Of Oral PHA-848125AC In Patients With Thymic Carcinoma
Conditions: Thymic Carcinoma
Intervention: Milciclib Maleate
Conditions: Thymic Carcinoma
Intervention: Milciclib Maleate
January 22, 2019
236710
NCT00295984
Completed
Completed
Nicotine Skin Patch in Treating Patients With Kaposi's Sarcoma
Conditions: Sarcoma
Intervention: Nicotine
Conditions: Sarcoma
Intervention: Nicotine
June 18, 2013
236711
NCT00438009
Completed
Completed
A Safety Study of Two Intratumoural Doses of Coxsackievirus Type A21 in Melanoma Patients (PSX-X03)
Conditions: Stage IV Melanoma
Intervention: Coxsackievirus A21
Conditions: Stage IV Melanoma
Intervention: Coxsackievirus A21
June 26, 2019
236712
NCT00287495
Terminated
Terminated
BAY 43-9006 (Sorafenib) to Treat Patients With Kaposi's Sarcoma
Conditions: Kaposi's Sarcoma; HHV-8; KSHV
Intervention: BAY 43-9006
Conditions: Kaposi's Sarcoma; HHV-8; KSHV
Intervention: BAY 43-9006
December 6, 2019
236713
NCT00429312
Completed
Completed
A Study of Recombinant Vaccinia Virus to Treat Malignant Melanoma
Conditions: Melanoma
Intervention: JX-594
Conditions: Melanoma
Intervention: JX-594
January 13, 2015
236714
NCT00006361
Completed
Completed
SU5416 in Treating Patients With Advanced or Recurrent Cancer of the Head and Neck
Conditions: Carcinoma of Unknown Primary; Head and Neck Cancer; Non-melanomatous Skin Cancer
Intervention: Semaxanib
Conditions: Carcinoma of Unknown Primary; Head and Neck Cancer; Non-melanomatous Skin Cancer
Intervention: Semaxanib
December 3, 2009
236715
NCT00965250
Completed
Completed
Multicenter Phase II Study of IMC-A12 in Patients With Thymoma and Thymic Carcinoma Who Have Been Previously Treated With Chemotherapy
Conditions: Thymoma; Thymic Carcinoma; Thymic Carcinoid; Thymic Neuroendocrine Tumors
Intervention: IMC-12
Conditions: Thymoma; Thymic Carcinoma; Thymic Carcinoid; Thymic Neuroendocrine Tumors
Intervention: IMC-12
October 31, 2016
236716
NCT00265902
Terminated
Terminated
Infrared Thermography in Finding Skin Lesions in Patients With Kaposi's Sarcoma
Conditions: Sarcoma
Intervention: Diagnostic Imaging
Conditions: Sarcoma
Intervention: Diagnostic Imaging
March 18, 2019
236717
NCT00295958
Completed
Completed
LMB-2 Immunotoxin and Vaccine Therapy in Treating Patients With Metastatic Melanoma That Cannot Be Removed By Surgery
Conditions: Melanoma (Skin); Non-melanomatous Skin Cancer
Intervention: LMB-2 Immunotoxin, MART-1 Antigen, Gp100 Antigen, Incomplete Freund's Adjuvant
Conditions: Melanoma (Skin); Non-melanomatous Skin Cancer
Intervention: LMB-2 Immunotoxin, MART-1 Antigen, Gp100 Antigen, Incomplete Freund's Adjuvant
June 12, 2012
236718
NCT00295906
Unknown status
Unknown status
Computer-Based Continuing Education for Doctors in Examination and Counseling of Patients on Skin Cancer or Weight Control
Conditions: Melanoma (Skin); Non-melanomatous Skin Cancer
Intervention: Educational Intervention, Internet-based Intervention
Conditions: Melanoma (Skin); Non-melanomatous Skin Cancer
Intervention: Educational Intervention, Internet-based Intervention
December 17, 2013
236719
NCT00111046
Unknown status
Unknown status
Pain Relief - Tramadol Versus Ibuprofen
Conditions: Choroidal Melanoma; Melanoma; Eye Neoplasms
Intervention: Ibuprofen, Tramadol
Conditions: Choroidal Melanoma; Melanoma; Eye Neoplasms
Intervention: Ibuprofen, Tramadol
November 9, 2005
236720
NCT00269100
Terminated
Terminated
Prevention of Bacteremia Induced by Debridement of Pressure Ulcer
Conditions: Pressure Ulcers; Bacteremia
Conditions: Pressure Ulcers; Bacteremia
April 19, 2007
236721
NCT00189332
Completed
Completed
Use of 852A in Metastatic Cutaneous Melanoma.
Conditions: Melanoma; Unresectable Metatstatic Cutaneous Melanoma
Intervention: 852A
Conditions: Melanoma; Unresectable Metatstatic Cutaneous Melanoma
Intervention: 852A
October 24, 2008
236722
NCT00818090
Terminated
Terminated
Paclitaxel and Cisplatin for Thymic Neoplasm
Conditions: Thymoma; Thymic Carcinoma
Intervention: Paclitaxel And Cisplatin
Conditions: Thymoma; Thymic Carcinoma
Intervention: Paclitaxel And Cisplatin
April 11, 2013
236723
NCT01062477
Completed
Completed
A Study of DTaP//PRP-T Combined Vaccine (ACTACEL) Versus Local DTaP and Act-HIB Monovalent Vaccine in Healthy Infants
Conditions: Diphtheria; Tetanus; Pertussis; Haemophilus Influenzae Type B
Intervention: DTaP//PRP-T Combined Vaccine, DTaP//PRP-T Combined Vaccine, DTaP Combined Vaccine And PRP-Tetanus Conjugate Vaccine
Conditions: Diphtheria; Tetanus; Pertussis; Haemophilus Influenzae Type B
Intervention: DTaP//PRP-T Combined Vaccine, DTaP//PRP-T Combined Vaccine, DTaP Combined Vaccine And PRP-Tetanus Conjugate Vaccine
December 12, 2011
236724
NCT00110019
Completed
Completed
Carboplatin and Paclitaxel With or Without Sorafenib Tosylate in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery
Conditions: Mucosal Melanoma; Recurrent Melanoma; Stage IIIA Skin Melanoma; Stage IIIB Skin Melanoma; Stage IIIC Skin Melanoma; Stage IV Skin Melanoma
Intervention: Carboplatin, Laboratory Biomarker Analysis, Paclitaxel, Pharmacological Study, Placebo, Sorafenib Tosylate
Conditions: Mucosal Melanoma; Recurrent Melanoma; Stage IIIA Skin Melanoma; Stage IIIB Skin Melanoma; Stage IIIC Skin Melanoma; Stage IV Skin Melanoma
Intervention: Carboplatin, Laboratory Biomarker Analysis, Paclitaxel, Pharmacological Study, Placebo, Sorafenib Tosylate
September 28, 2015
236725
NCT00718809
Terminated
Terminated
Saracatinib in Treating Patients With Relapsed or Refractory Thymoma or Thymic Cancer
Conditions: Invasive Thymoma and Thymic Carcinoma; Recurrent Thymoma and Thymic Carcinoma; Stage III Thymoma; Stage IVA Thymoma; Stage IVB Thymoma
Intervention: Saracatinib
Conditions: Invasive Thymoma and Thymic Carcinoma; Recurrent Thymoma and Thymic Carcinoma; Stage III Thymoma; Stage IVA Thymoma; Stage IVB Thymoma
Intervention: Saracatinib
June 5, 2015
236726
NCT00715000
Completed
Completed
Oral Versus Intravenous Rehydration for Prevention of Dehydration in Premature Babies, During the First Days of Life.
Conditions: Low Birth Weight Infant; Enteral Nutrition
Intervention: Oral Rehydration Therapy, Classical Hydration Via Intravenous Infusion
Conditions: Low Birth Weight Infant; Enteral Nutrition
Intervention: Oral Rehydration Therapy, Classical Hydration Via Intravenous Infusion
April 24, 2013
236727
NCT00096538
Completed
Completed
Valganciclovir in Treating Patients With Classic Non-HIV-Associated Kaposi's Sarcoma
Conditions: Sarcoma
Intervention: Valganciclovir
Conditions: Sarcoma
Intervention: Valganciclovir
October 21, 2015
236728
NCT00235482
Completed
Completed
Intratumoural Administration of Coxsackievirus A21 for the Control of Malignant Melanoma (PXS-X02)
Conditions: Malignant Melanoma
Intervention: Coxsackievirus A21
Conditions: Malignant Melanoma
Intervention: Coxsackievirus A21
June 26, 2019
236729
NCT00156559
Completed
Completed
MMR and Varicella Vaccine in Premature Infants
Conditions: Chickenpox; Rubella; Rubeola; Mumps
Conditions: Chickenpox; Rubella; Rubeola; Mumps
September 15, 2015
236730
NCT00090987
Completed
Completed
Imatinib Mesylate in Treating Patients With HIV-Related Kaposi's Sarcoma
Conditions: Sarcoma
Intervention: Imatinib Mesylate
Conditions: Sarcoma
Intervention: Imatinib Mesylate
May 3, 2018
236731
NCT00005042
Completed
Completed
SU5416 in Treating Patients With AIDS-Related Kaposi's Sarcoma
Conditions: Sarcoma
Intervention: Semaxanib
Conditions: Sarcoma
Intervention: Semaxanib
August 28, 2014
236732
NCT00116597
Completed
Completed
Active Specific Intranodal Immunotherapy of Recombinant Vaccinia Virus in Locally Advanced to Metastatic Melanoma
Conditions: Melanoma
Intervention: Intranodal Immunization With A Recombinant Vaccinia Virus Expressing 5 Transgenes, Intranodal Booster Immunizations With Synthetic Melanoma Associated Epitopes
Conditions: Melanoma
Intervention: Intranodal Immunization With A Recombinant Vaccinia Virus Expressing 5 Transgenes, Intranodal Booster Immunizations With Synthetic Melanoma Associated Epitopes
December 1, 2009
236733
NCT00094107
Completed
Completed
Anti-Angiogenesis Agent AG-013736 In Patients With Metastatic Melanoma
Conditions: Melanoma; Skin Neoplasms
Intervention: Axitinib [AG-013736]
Conditions: Melanoma; Skin Neoplasms
Intervention: Axitinib [AG-013736]
June 21, 2012
236734
NCT00003720
Completed
Completed
SU5416 in Treating Patients With AIDS-Related Kaposi's Sarcoma
Conditions: Sarcoma
Intervention: Semaxanib
Conditions: Sarcoma
Intervention: Semaxanib
August 22, 2012
236735
NCT00589290
Completed
Completed
Belinostat (PXD101) to Treat Tumors of the Thymus at an Advanced Stage
Conditions: Thymoma; Thymic Carcinoma
Intervention: Belinostat (PDX101)
Conditions: Thymoma; Thymic Carcinoma
Intervention: Belinostat (PDX101)
September 29, 2015
236736
NCT00006222
Terminated
Terminated
EMD 121974 in Treating Patients With HIV-Related Kaposi's Sarcoma
Conditions: Sarcoma
Intervention: Cilengitide
Conditions: Sarcoma
Intervention: Cilengitide
May 31, 2013
236737
NCT00002985
Completed
Completed
Doxorubicin in Treating Patients With AIDS-Related Kaposi's Sarcoma
Conditions: Sarcoma
Intervention: Daunorubicin Hydrochloride, Pegylated Liposomal Doxorubicin Hydrochloride
Conditions: Sarcoma
Intervention: Daunorubicin Hydrochloride, Pegylated Liposomal Doxorubicin Hydrochloride
February 1, 2013
236738
NCT00019240
Completed
Completed
Antiviral Therapy in Treating Patients With Kaposi's Sarcoma With or Without HIV Infection
Conditions: Sarcoma
Intervention: Cidofovir
Conditions: Sarcoma
Intervention: Cidofovir
June 19, 2013
236739
NCT00019123
Completed
Completed
Thalidomide in Treating Patients With HIV-Associated Kaposi's Sarcoma
Conditions: Sarcoma
Intervention: Thalidomide
Conditions: Sarcoma
Intervention: Thalidomide
August 14, 2013
236740
NCT00083252
Completed
Completed
Study of Talabostat and Cisplatin in Advanced Melanoma
Conditions: Melanoma; Skin Cancer
Intervention: Talabostat (PT-100) Tablets, Cisplatin
Conditions: Melanoma; Skin Cancer
Intervention: Talabostat (PT-100) Tablets, Cisplatin
June 7, 2007
236741
NCT00083239
Completed
Completed
Study of Talabostat in Advanced Melanoma
Conditions: Melanoma; Skin Cancer
Intervention: Talabostat (PT-100) Tablets
Conditions: Melanoma; Skin Cancer
Intervention: Talabostat (PT-100) Tablets
June 7, 2007
236742
NCT00003207
Completed
Completed
Liposomal Doxorubicin and PSC 833 in Treating Patients With AIDS-Related Kaposi's Sarcoma or Other Advanced Cancers
Conditions: Sarcoma; Unspecified Adult Solid Tumor, Protocol Specific
Intervention: Pegylated Liposomal Doxorubicin Hydrochloride, PSC 833
Conditions: Sarcoma; Unspecified Adult Solid Tumor, Protocol Specific
Intervention: Pegylated Liposomal Doxorubicin Hydrochloride, PSC 833
April 11, 2013
236743
NCT00075777
Completed
Completed
Valproic Acid in Treating Patients With Kaposi's Sarcoma
Conditions: Sarcoma
Intervention: Valproic Acid
Conditions: Sarcoma
Intervention: Valproic Acid
August 27, 2014
236744
NCT00495950
Completed
Completed
Prospective Measurement of Post-Treatment Lymphedema
Conditions: Melanoma
Intervention: Questionnaire
Conditions: Melanoma
Intervention: Questionnaire
November 23, 2016
236745
NCT00025012
Completed
Completed
Isotretinoin in Preventing Skin Cancer
Conditions: Melanoma (Skin); Non-melanomatous Skin Cancer
Intervention: Isotretinoin
Conditions: Melanoma (Skin); Non-melanomatous Skin Cancer
Intervention: Isotretinoin
June 17, 2013
236746
NCT03695042
Enrolling by invitation
Enrolling by invitation
Blood Flow Restriction Concussion
Conditions: Concussion Post Syndrome
Intervention: Blood Flow Restriction Training With Exercise
Conditions: Concussion Post Syndrome
Intervention: Blood Flow Restriction Training With Exercise
September 6, 2019
236747
NCT01190722
Withdrawn
Withdrawn
A Study Comparing Etoricoxib and Diclofenac Sodium in Post Hallux Valgus Surgery Pain
Conditions: Hallux Valgus; Postoperative Pain
Intervention: Etoricoxib, Diclofenac
Conditions: Hallux Valgus; Postoperative Pain
Intervention: Etoricoxib, Diclofenac
November 29, 2017
236748
NCT00024024
Completed
Completed
BMS-275291 in Treating Patients With HIV-Related Kaposi's Sarcoma
Conditions: Sarcoma
Intervention: Rebimastat
Conditions: Sarcoma
Intervention: Rebimastat
February 8, 2013
236749
NCT00017147
Completed
Completed
S0001 RT and Carmustine With or Without O6BG in Patients With New Glioblastoma Multiforme or Gliosarcoma
Conditions: Malignant Neoplasms of Eye, Brain and Other Parts of Central Nervous System
Intervention: Carmustine, Radiation Therapy, O6-Benzylguanine
Conditions: Malignant Neoplasms of Eye, Brain and Other Parts of Central Nervous System
Intervention: Carmustine, Radiation Therapy, O6-Benzylguanine
January 28, 2013
236750
NCT00003350
Completed
Completed
Paclitaxel Compared With Doxorubicin in Treating Patients With Advanced AIDS-Related Kaposi's Sarcoma
Conditions: AIDS-related Kaposi Sarcoma
Intervention: Paclitaxel, Pegylated Liposomal Doxorubicin Hydrochloride, Laboratory Biomarker Analysis, Quality-of-life Assessment
Conditions: AIDS-related Kaposi Sarcoma
Intervention: Paclitaxel, Pegylated Liposomal Doxorubicin Hydrochloride, Laboratory Biomarker Analysis, Quality-of-life Assessment
January 9, 2013
First Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 … 4715 4716 4717 4718 4719 4720 4721 4722 4723 4724 4725 4726 4727 4728 4729 4730 4731 4732 4733 4734 4735 4736 4737 4738 4739 4740 4741 4742 4743 4744 4745 4746 4747 4748 4749 4750 4751 4752 4753 4754 4755 4756 4757 4758 4759 Next Last
Last Updated
The last updated date is the most recent date when changes to a clinical trial were
submitted to ClinicalTrials.gov. There is often a delay of a few days before the
updated trial is available on the clinical trials website.
Specify a From date to find the most recently changed trials. Specify both From and To dates to find trials changed during a certain period. If no dates are given, all trials will be included.
Dates should be given in a MM/DD/YYYY format, as in 1/1/2006 or 8/17/2004.
Specify a From date to find the most recently changed trials. Specify both From and To dates to find trials changed during a certain period. If no dates are given, all trials will be included.
Dates should be given in a MM/DD/YYYY format, as in 1/1/2006 or 8/17/2004.
First Received
The first received date is the date when the clinical trial was first submitted
to ClinicalTrials.gov. There is often a delay of a few days before the
trial is available on the clinical trials website.
Clinical trial records are often updated after they have been published. The first received, last updated, start, and end dates are all displayed in the full text view of the clinical trial.
Specify a From date to find the most recent trials. Specify both From and To dates to find trials submitted during a certain period. If no dates are given, all trials will be included.
Dates should be given in a MM/DD/YYYY format, as in 1/1/2006 or 8/17/2004.
Clinical trial records are often updated after they have been published. The first received, last updated, start, and end dates are all displayed in the full text view of the clinical trial.
Specify a From date to find the most recent trials. Specify both From and To dates to find trials submitted during a certain period. If no dates are given, all trials will be included.
Dates should be given in a MM/DD/YYYY format, as in 1/1/2006 or 8/17/2004.
Safety Issue
If selected, restricts search results to those studies which have
an outcome measure designated as a safety issue. Note that this is a
poor estimate of the safety of a treatment or intervention, but it is
all we have now.
Funded By
Studies are supported by one or more organizations called sponsors.
Support includes contributions of facilities, expertise, and/or financial resources.
All sponsors in the database have been assigned one of the following organization types:
National Institutes of Health (NIH)
Other U.S. Federal Agency - Food and Drug Administration (FDA), Centers for Disease Control and Prevention (CDC), Department of Veterans Affairs (VA), etc.
Industry - the pharmaceutical companies
University/Organization - all others, including community-based organizations
Click the check box to the left of each organization type that you wish to include in your search. You can select more than one organization type. If you do not select any type, all types will be included.
National Institutes of Health (NIH)
Other U.S. Federal Agency - Food and Drug Administration (FDA), Centers for Disease Control and Prevention (CDC), Department of Veterans Affairs (VA), etc.
Industry - the pharmaceutical companies
University/Organization - all others, including community-based organizations
Click the check box to the left of each organization type that you wish to include in your search. You can select more than one organization type. If you do not select any type, all types will be included.
Study Phase
Click the check box to the left of each study phase that you wish to include in your search. You can select more than one study phase. If you do not select a any phase, all phases will be included.
Most clinical trials are designated as phase 1, 2, 3, or 4, based on the type of questions
that study is seeking to answer:
In Phase 1 (Phase I) clinical trials, researchers test a new drug or treatment in a small group of people (20-80) for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
In Phase 2 (Phase II) clinical trials, the study drug or treatment is given to a larger group of people (100-300) to see if it is effective and to further evaluate its safety.
In Phase 3 (Phase III) clinical trials, the study drug or treatment is given to large groups of people (1,000-3,000) to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
In Phase 4 (Phase IV) clinical trials, post marketing studies delineate additional information including the drug's risks, benefits, and optimal use.
These phases are defined by the Food and Drug Administration in the Code of Federal Regulations.
In Phase 1 (Phase I) clinical trials, researchers test a new drug or treatment in a small group of people (20-80) for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
In Phase 2 (Phase II) clinical trials, the study drug or treatment is given to a larger group of people (100-300) to see if it is effective and to further evaluate its safety.
In Phase 3 (Phase III) clinical trials, the study drug or treatment is given to large groups of people (1,000-3,000) to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
In Phase 4 (Phase IV) clinical trials, post marketing studies delineate additional information including the drug's risks, benefits, and optimal use.
These phases are defined by the Food and Drug Administration in the Code of Federal Regulations.
Click the check box to the left of each study phase that you wish to include in your search. You can select more than one study phase. If you do not select a any phase, all phases will be included.
Age Group
Studies may be designed for participants of particular ages:
Children (birth-17 yrs old)
Adults (18-65 yrs old)
Senior (66+ yrs old)
Click the check box to the left of each age group that you wish to include in your search. You can select more than one age group. If you do not select a any group, all groups will be included.
Children (birth-17 yrs old)
Adults (18-65 yrs old)
Senior (66+ yrs old)
Click the check box to the left of each age group that you wish to include in your search. You can select more than one age group. If you do not select a any group, all groups will be included.
Gender
Searches can be restricted to studies which accept female or male participants.
Location Terms
If you are interested in a specific city (such as Los Angeles) or facility
name (such as the Mayo Clinic), enter it as a location term. Not all studies
include this level of detail, but if they do, this will find them.
Countries and States
Trials are often conducted at many locations around the world.
Select up to three locations to find trials conducted in
specific countries. Some countries (currently limited to the
United States, Canada, and Australia), locations can be narrowed
further by selecting a state.
Study IDs
Each trial is assigned one or more identification numbers by the institute, agency,
or organization sponsoring the trial. In addition, clinical trials assigns a
unique NCT identifier of the form NCTxxxxxxxx where each x is a numeric digit.
Use this box to search for a trial by NCT identifier or any other study
identification numbers.
Examples:
Examples:
NCT00001789
97-h-0197
ia0006
actg 076
97-h-0197
ia0006
actg 076
Sponsor (Lead)
Use this box to specify the name of an institute, organization, or company that is
conducting a trial.
It is common for several organizations to collaborate by providing funding, facilities, experimental treatments, etc. Which organization is considered the sponsor is decided by the data provider.
A search in this area will check only the sponsor field. To also look for collaborators, use the Sponsor/Collaborators search box.
When the Exact Match checkbox is checked, the sponsor name in the study must exactly match the sponsor name in the search. For example, if unchecked, a search for Merck in the lead sponsor field will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.
Examples:
National Cancer Institute
Mayo Clinic
Bristol-Myers Squibb
It is common for several organizations to collaborate by providing funding, facilities, experimental treatments, etc. Which organization is considered the sponsor is decided by the data provider.
A search in this area will check only the sponsor field. To also look for collaborators, use the Sponsor/Collaborators search box.
When the Exact Match checkbox is checked, the sponsor name in the study must exactly match the sponsor name in the search. For example, if unchecked, a search for Merck in the lead sponsor field will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.
Examples:
National Cancer Institute
Mayo Clinic
Bristol-Myers Squibb
Sponsor/Collaborators
Use this box to specify institutes, organizations, or companies that are
conducting or otherwise supporting a trial.
It is common for several organizations to collaborate by providing funding, facilities, experimental treatments, etc. Which organization is considered the sponsor is decided by the data provider.
Searching this area will look in both the sponsor field and in the collaborators field. To only look in the sponsor field, use the Sponsor (Lead) search box.
When the Exact Match checkbox is checked, the name in the study must exactly match the name in the search. For example, if unchecked, a search for Merck will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.
Examples:
National Cancer Institute
Mayo Clinic
Bristol-Myers Squibb
It is common for several organizations to collaborate by providing funding, facilities, experimental treatments, etc. Which organization is considered the sponsor is decided by the data provider.
Searching this area will look in both the sponsor field and in the collaborators field. To only look in the sponsor field, use the Sponsor (Lead) search box.
When the Exact Match checkbox is checked, the name in the study must exactly match the name in the search. For example, if unchecked, a search for Merck will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.
Examples:
National Cancer Institute
Mayo Clinic
Bristol-Myers Squibb
Outcome Measures
Use this box to specify an outcome measure used to evaluate trial results.
Examples:
weight loss
heart failure
suicide
Outcome measures are used to evaluate trial results. For example, an obesity treatment
might be evaluated by a measure of weight loss after 6 months. Measures can also be used
to quantify side effects, such as number of myocardial infarctions,
number of patients with heart arrhythmia, number of suicides, etc.
Use this box to specify an outcome measure used to evaluate trial results.
Examples:
weight loss
heart failure
suicide
Interventions
Use this box to specify drugs, devices, procedures, or vaccines used in a trial.
Examples:
clofibrate
cyclosporine
vitamin e
Interventions refer to the drug, vaccine, procedure, device, or other potential treatment being studied.
Interventions can also include less intrusive possibilities such as surveys, education, and interviews.
Use this box to specify drugs, devices, procedures, or vaccines used in a trial.
Examples:
clofibrate
cyclosporine
vitamin e
Conditions
Use this box to specify the conditions being studied.
Examples:
lupus
heart attack
leukemia
risk factors for breast cancer
Conditions usually refer to a disease, disorder, syndrome, illness, or injury. In ClinicalTrials.gov,
conditions include any health issue worth studying, such as lifespan, quality of life, health risks, etc.
Use this box to specify the conditions being studied.
Examples:
lupus
heart attack
leukemia
risk factors for breast cancer
Study Type
There are three types of studies available in ClinicalTrials.gov:
There are three types of studies available in ClinicalTrials.gov:
Interventional:
Observational:
Expanded Access:
Studies where individuals are assigned to receive specific interventions.
Participants may receive diagnostic, therapeutic or other types of interventions.
Assignment of the intervention may or may not be random.
Individuals are tracked and biomedical and/or health outcomes are assessed.
Observational:
Studies without an intervention.
Studies where biomedical and/or health outcomes are assessed in a pre-defined group of individuals.
Participants may receive diagnostic, therapeutic, or other interventions, but the investigator
does not assign specific interventions to the participants of the study.
Expanded Access:
Records describing the procedure for obtaining an experimental drug or device for patients who
are failing on currently available treatments for their condition and also are unable to
participate in ongoing clinical trials. Expanded Access records are used to register all
types of non-protocol access to experimental treatments, including protocol exception,
single-patient IND, treatment IND, compassionate use, emergency use, continued access and parallel track.
Study Results
Searches can be restricted to studies with or without results.
The inclusion of study results is a relatively new feature of ClinicalTrials.gov. Collection of results began in September of 2008. Almost all older studies and some newer studies do not include results. As time goes on, there will be more results available.
The inclusion of study results is a relatively new feature of ClinicalTrials.gov. Collection of results began in September of 2008. Almost all older studies and some newer studies do not include results. As time goes on, there will be more results available.
Recruitment Status
Also known as Enrollment Status.
Not all clinical trials in this database are accepting new participants. If you are looking for studies that are currently recruiting participants, will be recruiting in the future, or are about drugs that are available for expanded access, select Open Studies in the recruitment menu.
If you are interested in all trials, whether they are recruiting new participants or not, leave the menu with All Studies selected.
Trials may not be recruiting because they are full, completed, or halted for various reasons. In addition, some trials have very restrictive eligibility requirements and must seek participants by invitation only. To see these studies, Select Closed Studies in the recruitment menu.
Full list of all possible recruitment status values:
Open recruitment status values:
Closed recruitment status values:
Values are color coded (as shown) in the search results.
Not all clinical trials in this database are accepting new participants. If you are looking for studies that are currently recruiting participants, will be recruiting in the future, or are about drugs that are available for expanded access, select Open Studies in the recruitment menu.
If you are interested in all trials, whether they are recruiting new participants or not, leave the menu with All Studies selected.
Trials may not be recruiting because they are full, completed, or halted for various reasons. In addition, some trials have very restrictive eligibility requirements and must seek participants by invitation only. To see these studies, Select Closed Studies in the recruitment menu.
Full list of all possible recruitment status values:
Open recruitment status values:
Recruiting,
Not yet recruiting, or
Available for expanded access.
Not yet recruiting, or
Available for expanded access.
Closed recruitment status values:
Active, not recruiting,
Completed,
Terminated,
Suspended,
Withdrawn,
Enrolling by invitation,
Temporarily not available for expanded access,
No longer available for expanded access,
Approved for marketing, or
Unknown.
Completed,
Terminated,
Suspended,
Withdrawn,
Enrolling by invitation,
Temporarily not available for expanded access,
No longer available for expanded access,
Approved for marketing, or
Unknown.
Search Terms
Use this box to specify general search terms found anywhere in the trial record.
Multiple terms can be separated by an AND (all uppercase).
Examples:
type ii diabetes
veterans affairs medical center
heart attacks in older adults
nhlbi AND heart disease
Cisplatin AND safety study
Multiple terms can be separated by an AND (all uppercase).
Examples:
type ii diabetes
veterans affairs medical center
heart attacks in older adults
nhlbi AND heart disease
Cisplatin AND safety study
Help for Searching clinical trials
Help Topics:
Basic Search:
On the Basic Search page, enter a word or word(s) that you want to use to find studies.
These may include diseases, interventions, and/or locations.
Medical terms are often several words long, such as Percutaneous Coronary Intervention. To only find studies where the words are together as a phrase, put the term in quotes (e.g., "Percutaneous Coronary Intervention"). If you search for a multi-word term without quotes, studies with all words together as a phrase will appear higher in the results list than studies where the words are separated and spread throughout the document. For example, a search for Heart Attack will list a study about,
A search for "Heart Attack" would not find the second study. Synonyms are known for some terms and are used where possible. For example, a search for Heart Attack will also find occurrences of Myocardial Infarction.
Medical terms are often several words long, such as Percutaneous Coronary Intervention. To only find studies where the words are together as a phrase, put the term in quotes (e.g., "Percutaneous Coronary Intervention"). If you search for a multi-word term without quotes, studies with all words together as a phrase will appear higher in the results list than studies where the words are separated and spread throughout the document. For example, a search for Heart Attack will list a study about,
Use of a Pacemaker Following a Heart Attack.
higher than the study,
Heart Defects and Transient Ischemic Attacks
A search for "Heart Attack" would not find the second study. Synonyms are known for some terms and are used where possible. For example, a search for Heart Attack will also find occurrences of Myocardial Infarction.
Advanced Search:
Many searches are a single term and can be performed with a few words in the
search box. But, sometimes you need more control. Click on the Advanced Search tab
(if starting a new search) or Refine Search tab (if modifying an existing search)
to show additional search fields.
The additional search fields can be used to limit your search results. Note that it is not necessary to fill in all the fields, only those that are needed for your search. If you are finding too few studies, consider clearing a field and searching again.
Search Terms:
Recruitment:
Interventions:
Outcomes Measures:
Sponsor/Collaborators:
Sponsor (Lead):
Study IDs:
Country/State:
Location Terms:
Gender:
Age Group:
Phase:
Funded By:
Safety Issue:
First Received:
Last Updated:
The additional search fields can be used to limit your search results. Note that it is not necessary to fill in all the fields, only those that are needed for your search. If you are finding too few studies, consider clearing a field and searching again.
Search Terms:
Performs a general search in all sections of the study record, including title,
description, conditions, interventions, locations, etc. Terms in this field are
searched the same as Basic Search.
Recruitment:
Limits search results to studies that are open or closed. New volunteers may be
able to participate in open studies, but not closed studies.
Open recruitment status values:
Closed recruitment status values:
Values are color coded (as shown) in the search results.
Study Results:Open recruitment status values:
Recruiting,
Not yet recruiting, or
Available for expanded access.
Not yet recruiting, or
Available for expanded access.
Closed recruitment status values:
Active, not recruiting,
Completed,
Terminated,
Suspended,
Withdrawn,
Enrolling by invitation,
Temporarily not available for expanded access,
No longer available for expanded access,
Approved for marketing, or
Unknown.
Completed,
Terminated,
Suspended,
Withdrawn,
Enrolling by invitation,
Temporarily not available for expanded access,
No longer available for expanded access,
Approved for marketing, or
Unknown.
Values are color coded (as shown) in the search results.
Limits search results based on whether the study has results or not:
Study Type:
All Studies,
Studies With Results, or
Studies Without Results
The inclusion of Study Results is a new feature of ClinicalTrials.gov.
Only a few studies have results available.Studies With Results, or
Studies Without Results
Limits search results to any of the following study types:
Conditions:
Interventional,
Observational, or
Expanded Access
Observational, or
Expanded Access
Performs a search on fields describing the diseases or conditions being studied.
Interventions:
Performs a search on fields listing the drugs or interventions being studied.
Outcomes Measures:
Performs a search on fields listing the outcome measures used to quantify study results.
Sponsor/Collaborators:
Performs a search on fields listing the sponsor and collaborators of a study.
When the Exact Match checkbox is checked, the sponsor/collaborator name in the study must exactly match the name in the search. For example, if unchecked, a search for Merck in the sponsor/collaborator field will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.
When the Exact Match checkbox is checked, the sponsor/collaborator name in the study must exactly match the name in the search. For example, if unchecked, a search for Merck in the sponsor/collaborator field will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.
Sponsor (Lead):
Performs a search on the sponsor field of a study.
It is common for several organizations to collaborate by providing funding, facilities, experimental treatments, etc. Which organization is considered the "sponsor" is decided by the data provider.
When the Exact Match checkbox is checked, the lead sponsor name in the study must exactly match the lead sponsor name in the search. For example, if unchecked, a search for Merck in the lead sponsor field will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.
It is common for several organizations to collaborate by providing funding, facilities, experimental treatments, etc. Which organization is considered the "sponsor" is decided by the data provider.
When the Exact Match checkbox is checked, the lead sponsor name in the study must exactly match the lead sponsor name in the search. For example, if unchecked, a search for Merck in the lead sponsor field will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.
Study IDs:
Performs a search on fields listing ID numbers.
Country/State:
Trials are often conducted at many locations around the world.
Select up to three locations to find trials conducted in
specific countries. Some countries (currently limited to the
United States, Canada, and Australia), locations can be narrowed
further by selecting a state (e.g., United States, Alabama).
Location Terms:
Finds studies in specific locations such as a city (Los Angeles) or facility (Mayo Clinic).
Not all studies include this level of detail, but if they do, this will find them.
Gender:
Limits search results to those studies that accept female or male participants.
Age Group:
Limits search results to those studies that include at least one of the specified age
ranges. More than one age group can be selected.
Phase:
Limits search results to studies that are labeled with at least one of the specified
phases. More than one Phase can be selected.
Funded By:
Limits search results to studies that have at least one sponsor of the specified types.
More than one sponsor type can be selected.
Safety Issue:
Limits search results to studies that have at least one outcome measure designated as a safety issue.
First Received:
Limits search results to studies that were received by clinical trials within a
specified date range. The "From" or "To" field can be left blank.
Last Updated:
Limits search results to studies that were modified within a
specified date range. The "From" or "To" field can be left blank.
Refine Search:
Searches display a list of studies found (List Results tab). If you are not content with
the search results, click on the Refine Search tab at the top of the list to modify your
search.
Add terms to empty fields to search within your current result. You can also add terms to fields that contain terms. For best results, use an AND (all upper case) as a separator between terms in the same field.
For example:
When you are done making changes, click Search to display the new results.
Add terms to empty fields to search within your current result. You can also add terms to fields that contain terms. For best results, use an AND (all upper case) as a separator between terms in the same field.
For example:
heart attack
heart attack AND aspirin
heart attack AND aspirin AND older adults
heart attack AND aspirin AND older adults AND California
heart attack AND aspirin
heart attack AND aspirin AND older adults
heart attack AND aspirin AND older adults AND California
When you are done making changes, click Search to display the new results.
Search Expressions:
Use AND (all upper case) to find study records that contain all terms connected by AND.
For example:
Use OR (all upper case) to find study records that contain either term connected by OR.
For example:
Use NOT (all upper case) to find study records that do not contain the term following NOT.
For example:
Likewise, AND, OR, NOT, and parentheses can be used to create more complicated search expressions.
For example:
Note that the use of AND and OR as logical operators can be confusing.
An appropriate search for a list such as,
To search for AND as a word, instead of using it as an operator, put it in quotes.
Likewise, you can quote OR, NOT, and parentheses.
For example:
prostate cancer AND radiation
heart disease AND stroke AND California
heart disease AND stroke AND California
Use OR (all upper case) to find study records that contain either term connected by OR.
For example:
Aspirin OR ibuprofen
heart disease OR heart attack
heart disease OR heart attack
Use NOT (all upper case) to find study records that do not contain the term following NOT.
For example:
Immunodeficiency NOT AIDS
Likewise, AND, OR, NOT, and parentheses can be used to create more complicated search expressions.
For example:
prostate cancer AND NOT ( radiation OR homeopathic remedies )
( heart disease OR heart attack ) AND ( stroke OR clot )
( heart disease OR heart attack ) AND ( stroke OR clot )
Note that the use of AND and OR as logical operators can be confusing.
An appropriate search for a list such as,
Ear, Nose, and Throat Conditions
is the expression
( Ear OR Nose OR Throat ) AND Conditions
Fortunately, search will do a pretty good job of finding the right studies either way.To search for AND as a word, instead of using it as an operator, put it in quotes.
Likewise, you can quote OR, NOT, and parentheses.